ArticleCurrent microbiology2026
Imported Cutaneous Leishmaniasis in India: Diagnosis and Treatment with Implications for Kala Azar Elimination.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cutaneous leishmaniasis (CL) is an emerging infection in Kerala state. Recent reports showed that Leishmania donovani is causing the dual manifestations, CL and visceral leishmaniasis (VL). In addition, the influx of migrants and returnees from other countries has introduced CL caused by non-endemic variants of Leishmania. A 46-year-old migrant worker from Nepal presented with a single erythematous nodule with crusting and erosions. It was diagnosed as CL through molecular diagnosis, and L. donovani was proven as the parasite by ITS-1 RFLP and sequencing. Additionally, the strain was identified as zymodeme MON-37 by sequence analysis of the 6-PGDH gene. Simultaneously, the phylogenetic analysis revealed the genetic relatedness of the current L. donovani isolate to those previously reported from Nepal. In contrast to the indigenous cases recorded in Kerala, this patient's serum samples showed an unusual rK-39 positivity, and Leishmania DNA was detected in circulation. The patient was successfully treated with intravenous amphotericin B. In the context of the nation attaining VL elimination, the differential tropism of Leishmania species, increasing migrations, and the detection and proper treatment of suspected cases are of high public health significance, as unnoticed cases can create new transmission pockets compromising the elimination efforts. This study signifies the importance of monitoring skin lesions among migrants and returnees from other countries to enhance the National Leishmaniasis Elimination strategies.
Indexed as
Identifiers
42363981What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.